FiercePharma

Data From Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral R

- Positive EVEREST II Results Published in The New England Journal of Medicine and Presented at the American College of Cardiology Conference NEW ORLEANS, April 4, 2011 /PRNewswire/ -- Abbott (NYSE: ...
Medscape

MitraClip Valve Repair Device Gets Expanded Indication

The US Food and Drug Administration (FDA) has expanded the indication for the MitraClip (Abbott) device to include patients with normal mitral valves who develop symptoms of heart failure and moderate ...
Nasdaq

Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...
Los Angeles Times

Treating the Heart Without the Need for Open Heart Surgery

With significant advancements in heart treatment, the days of open-heart surgery as the only option for complex heart conditions are mostly behind us. Today, minimally invasive procedures can be used ...